These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 1537129

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).
    Arnout J, Simoons M, de Bono D, Rapold HJ, Collen D, Verstraete M.
    J Am Coll Cardiol; 1992 Sep; 20(3):513-9. PubMed ID: 1512327
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
    Granger CB, Becker R, Tracy RP, Califf RM, Topol EJ, Pieper KS, Ross AM, Roth S, Lambrew C, Bovill EG.
    J Am Coll Cardiol; 1998 Mar 01; 31(3):497-505. PubMed ID: 9502626
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction.
    Bleich SD, Nichols TC, Schumacher RR, Cooke DH, Tate DA, Teichman SL.
    Am J Cardiol; 1990 Dec 15; 66(20):1412-7. PubMed ID: 2123602
    [Abstract] [Full Text] [Related]

  • 10. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators.
    Becker RC, Cannon CP, Tracy RP, Thompson B, Bovill EG, Desvigne-Nickens P, Randall AM, Knatternud G, Braunwald E.
    Am Heart J; 1996 Mar 15; 131(3):421-33. PubMed ID: 8604620
    [Abstract] [Full Text] [Related]

  • 11. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators.
    N Engl J Med; 1993 Nov 25; 329(22):1615-22. PubMed ID: 8232430
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
    Scharfstein JS, Abendschein DR, Eisenberg PR, George D, Cannon CP, Becker RC, Sobel B, Cupples LA, Braunwald E, Loscalzo J.
    Am J Cardiol; 1996 Sep 01; 78(5):503-10. PubMed ID: 8806332
    [Abstract] [Full Text] [Related]

  • 13. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
    Mombelli G, Marchetti O, Haeberli A, Straub PW.
    Am Heart J; 1998 Dec 01; 136(6):1106-13. PubMed ID: 9842027
    [Abstract] [Full Text] [Related]

  • 14. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction.
    Merlini PA, Bauer KA, Oltrona L, Ardissino D, Spinola A, Cattaneo M, Broccolino M, Mannucci PM, Rosenberg RD.
    J Am Coll Cardiol; 1995 Jan 01; 25(1):203-9. PubMed ID: 7798503
    [Abstract] [Full Text] [Related]

  • 15. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
    Simes RJ, Topol EJ, Holmes DR, White HD, Rutsch WR, Vahanian A, Simoons ML, Morris D, Betriu A, Califf RM.
    Circulation; 1995 Apr 01; 91(7):1923-8. PubMed ID: 7895348
    [Abstract] [Full Text] [Related]

  • 16. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
    Vanderschueren S, Barrios L, Kerdsinchai P, Van den Heuvel P, Hermans L, Vrolix M, De Man F, Benit E, Muyldermans L, Collen D.
    Circulation; 1995 Oct 15; 92(8):2044-9. PubMed ID: 7554180
    [Abstract] [Full Text] [Related]

  • 17. Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study Group.
    Arnold AE, Simoons ML, Van de Werf F, de Bono DP, Lubsen J, Tijssen JG, Serruys PW, Verstraete M.
    Circulation; 1992 Jul 15; 86(1):111-20. PubMed ID: 1617763
    [Abstract] [Full Text] [Related]

  • 18. Fibrin metabolism in patients with acute myocardial infarction during and after treatment with tissue-type plasminogen activator.
    Ring ME, Butman SM, Bruck DC, Feinberg WM, Corrigan JJ.
    Thromb Haemost; 1988 Dec 22; 60(3):428-33. PubMed ID: 2976994
    [Abstract] [Full Text] [Related]

  • 19. Heparin-induced prolongation of partial thromboplastin time after thrombolysis: relation to coronary artery patency. HART Investigators.
    Hsia J, Kleiman N, Aguirre F, Chaitman BR, Roberts R, Ross AM.
    J Am Coll Cardiol; 1992 Jul 22; 20(1):31-5. PubMed ID: 1607535
    [Abstract] [Full Text] [Related]

  • 20. Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction.
    Mombelli G, Im Hof V, Haeberli A, Straub PW.
    Circulation; 1984 Apr 22; 69(4):684-9. PubMed ID: 6697455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.